Indonesia, Thailand, Vietnam Testing H1N1 Alternative Drug
This article was originally published in PharmAsia News
Executive Summary
Indonesia, Thailand and Vietnam have become central locations for testing alternative medicines for the H1N1 virus because an increasing number of patients have become resistant to existing treatments. In all three countries, clinical trials have begun on peramivir as an alternative antiviral to Roche's Tamiflu (oseltamivir), the main treatment against the virus, but reportedly facing resistant strains of the flu that are developing as a result to overuse. The seasonal flu virus also is reported becoming resistant to Tamiflu. (Click here for more